The UK's National Health Service needs to form some kind of committee to evaluate the potential of diagnostic tests in order to take full advantage of advances in genomic medicine, says the Times Online's Mark Henderson. Two science think tanks at the University of Cambridge warn that "the potential of genetic testing to deliver better treatments at lower cost will be delayed unless there is a system to establish the benefits," Henderson says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.